Back to Top
Satumomab Biosimilar - Research Grade
$710.00 - $6,900.00
Satumomab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
tumour associated glycoprotein 72
Concentration
5mg/ml
Isotype
IgG4-G2a - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Tumor-associated glycoprotein 72 (TAG-72) is a mucin-like antigen overexpressed on many carcinomas and a classic marker in tumor-targeting research. Presented here is a non-therapeutic, unconjugated analog of satumomab, a recombinant monoclonal antibody against TAG-72, intended for research use only. Manufactured to in vivo standards and formulated with low endotoxin, it is available in scalable milligram to gram quantities for high-throughput and bulk laboratories. The antibody is useful for tumor-antigen binding functional assays, in vitro immunostaining-style screening, and in vivo tumor-localization models. Its scalable supply and batch consistency suit programs that require uniform reagent across many studies.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













